Terremoto Biosciences Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
54
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$108M
- Investors
-
10
Terremoto Biosciences General Information
Description
Developer of a drug development platform designed for small-molecule medicines. The company's platform delivers medicines with optimized clinical profiles, superior therapeutic benefits, and cures for diseases, enabling healthcare sector businesses to improve current medicines and create new therapies with optimized clinical profiles.
Contact Information
Website
terremotobio.comCorporate Office
- 230 East Grand Avenue
- Suite 200
- South San Francisco, CA 94080
- United States
Corporate Office
- 230 East Grand Avenue
- Suite 200
- South San Francisco, CA 94080
- United States
Terremoto Biosciences Timeline
Terremoto Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series C) | 15-Apr-2026 | $108M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series B) | 02-Nov-2023 | Completed | Clinical Trials - Phase 1 | |||
| 1. Early Stage VC (Series A) | 25-May-2022 | $75M | $75M | Completed | Clinical Trials - Phase 1 |
Terremoto Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Terremoto Biosciences Comparisons
Industry
Financing
Details
Terremoto Biosciences Competitors (2)
One of Terremoto Biosciences’s 2 competitors is Intellia Therapeutics, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Intellia Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Genetix Biotherapeutics | Private Equity-Backed | Somerville, MA |
Terremoto Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Terremoto Biosciences Patents
Terremoto Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026226730-A1 | A cdk2 inhibitor for use in the treatment of tumors | Pending | 23-Apr-2025 | ||
| WO-2026222210-A1 | Akt1 modulators for the treatment of cancer | Pending | 16-Apr-2025 | ||
| WO-2026206833-A1 | Imidazopyrazine modifiers of akt1 and uses thereof | Pending | 25-Mar-2025 | ||
| WO-2025217330-A1 | Cysteine covalent modifiers of akt1 and uses thereof | Pending | 10-Apr-2024 | ||
| WO-2025217336-A1 | Cysteine covalent modifiers of akt1 and uses thereof | Pending | 10-Apr-2024 | C07D487/04 |
Terremoto Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Terremoto Biosciences Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BeOne Medicines | Corporation | Minority | ||
| Cormorant Asset Management | PE/Buyout | Minority | ||
| Deep Track Capital | Venture Capital | Minority | ||
| Osage University Partners | Venture Capital | Minority | ||
| RA Capital Management | Asset Manager | Minority |
Terremoto Biosciences FAQs
-
When was Terremoto Biosciences founded?
Terremoto Biosciences was founded in 2021.
-
Where is Terremoto Biosciences headquartered?
Terremoto Biosciences is headquartered in South San Francisco, CA.
-
What is the size of Terremoto Biosciences?
Terremoto Biosciences has 54 total employees.
-
What industry is Terremoto Biosciences in?
Terremoto Biosciences’s primary industry is Drug Delivery.
-
Is Terremoto Biosciences a private or public company?
Terremoto Biosciences is a Private company.
-
What is Terremoto Biosciences’s current revenue?
The current revenue for Terremoto Biosciences is .
-
How much funding has Terremoto Biosciences raised over time?
Terremoto Biosciences has raised $358M.
-
Who are Terremoto Biosciences’s investors?
BeOne Medicines, Cormorant Asset Management, Deep Track Capital, Osage University Partners, and RA Capital Management are 5 of 10 investors who have invested in Terremoto Biosciences.
-
Who are Terremoto Biosciences’s competitors?
Intellia Therapeutics and Genetix Biotherapeutics are competitors of Terremoto Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
